Sign Up Today and Learn More About TytoCare Stock

Invest in or calculate the value of your shares in TytoCare or other pre-IPO companies through EquityZen's platform.

Get Started

TytoCare Stock

TytoCare is a mobile-health platform and device, allowing anyone to perform self physical examination and remote diagnosis.

About TytoCare Stock

Founded

2012

Headquarters

New York, NY, US

Notable Investor

Ping An Global Voyager Fund

Total Funding

56.7M

TytoCare is a mobile-health platform and device, allowing anyone to perform self physical examination and remote diagnosis. Tyto Care has three telehealth products: TytoHome™ for consumers, TytoPro™ for professionals, and TytoClinic™ for remote point-of-care locations. All solutions are designed to replicate a face-to-face clinician visit and include a hand-held modular examination tool for examining the heart, lungs, skin, throat, ears and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use. The Tyto platform also allows for simple integration with EHR systems and other telehealth platforms. TytoCare was founded by Dedi Gilad, Ofer Tzadik and industry experts in 2012 with a vision to put health in the hands of the consumer.

Investors in TytoCare

Discover investors in TytoCare stock and explore their portfolio companies

TytoCare Management

Leadership team at TytoCare

VP Product

Ophir Lotan

COO & Co-Founder

Ofer Tzadik

Locked Features

Join now and verify your accreditation status to gain access to:

  • TytoCare current valuation
  • TytoCare stock price
  • Available deals in TytoCare and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in TytoCare stock?

Accredited investors can buy pre-IPO stock in companies like TytoCare through EquityZen funds. These investments are made available by existing TytoCare shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell TytoCare stock?

Shareholders can sell their TytoCare stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."